Low Dose Aspirin Studied With the AggreGuide

This study is to determine whether the AggreGuide platelet aggregometer can discern the effect of low dose aspirin on subjects platelet aggregation using arachidonic acid as the agonist.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Platelet Aggregation Behavior Inhibition, Psychological

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Aggredyne, Inc.

Houston, Texas, 77099, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

adults

Exclusion criteria

aspirin contraindications
anticoagulants
aspirin past week

Sponsors and collaborators

Lead sponsor

Edward R. Teitel, M.D.

Industry

Registry information

Official study title

Low Dose Aspirin Study With the AggreGuide

Important dates

Study start: 2012
Primary completion: 2012
Study completion: 2012
First posted: May 23, 2012
Registry last updated: Jul 17, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed